Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is pseudomyxoma peritonei?
Pseudomyxoma peritonei (PMP) is an uncommon condition in which mucus-producing tumor cells spread across the lining of the abdomen (the peritoneum) and slowly fill the belly with thick, jelly-like mucus — sometimes called 'jelly belly.' It usually begins as a small tumor of the appendix that bursts and seeds the abdominal cavity, although it can occasionally arise from the ovary or bowel. Most forms grow slowly and rarely spread through the bloodstream to distant organs; instead, the problem is that the mucus and tumor build up inside the abdomen, pressing on organs over time. Because of this distinctive behavior, the most effective treatment is a specialized operation to remove all visible disease, combined with heated chemotherapy delivered directly into the abdomen, done at experienced centers.
The main types
Doctors group pseudomyxoma peritonei by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Low-grade mucinous (DPAM) | The most common, slow-growing form (disseminated peritoneal adenomucinosis); it makes abundant mucus but the cells look bland and rarely spread outside the abdomen. |
| High-grade mucinous (PMCA) | A more aggressive form (peritoneal mucinous carcinomatosis) with more cancerous-looking cells; it behaves more like an invasive cancer and has a higher chance of spread. |
| High-grade with signet-ring cells | The most aggressive subtype, defined by a specific worrisome cell type; it needs the most intensive treatment and is watched most closely. |
Staging, in plain terms
Pseudomyxoma peritonei is not staged with ordinary TNM numbers. What matters most is the grade (how aggressive the cells look) and how much of the abdomen is involved. Surgeons measure the extent using a Peritoneal Cancer Index (PCI), which scores how much tumor is present in each region of the belly, and they assess whether all visible disease can be removed (a 'complete cytoreduction'). These two things — grade and completeness of removal — predict outcome better than any stage number.
| Grade-based, with surgical extent (PCI) — not standard TNM | What it generally means |
|---|---|
| Low burden, completely removable | Mucus and tumor are limited enough that surgery can remove all visible disease. Combined with heated chemotherapy, this offers the best long-term control, often for many years. |
| Extensive but operable | Widespread mucus throughout the abdomen that still can be cleared with a long, specialized operation at an expert center; completeness of removal is the key goal. |
| Unresectable or high-grade spread | Disease too extensive to remove completely, or aggressive high-grade tumor; treated with chemotherapy and procedures to relieve symptoms, with surgery used to debulk when helpful. |
The standard of care
Pseudomyxoma Peritonei is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Cytoreductive surgery (CRS)
A long, specialized operation that removes all visible mucus and tumor from the abdominal lining and any involved organs (such as the appendix, parts of the bowel, the omentum, or ovaries). Removing every visible deposit is the single most important factor for a good outcome.
Heated chemotherapy in the abdomen (HIPEC)
Right after surgery, warmed chemotherapy is circulated through the open abdomen for about an hour to kill microscopic cells left behind. The heat and direct contact make it more effective while limiting whole-body side effects.
Systemic chemotherapy (selected cases)
Intravenous chemotherapy is added mainly for high-grade or unresectable disease, or when the tumor behaves like an invasive colon-type cancer.
Watchful waiting and repeat surgery
Because low-grade disease grows slowly, some patients are monitored over time, and surgery can be repeated if mucus rebuilds, since the disease tends to stay within the abdomen.
How radiation treatment works
Radiation damages the DNA inside tumor cells so they cannot keep growing. Pseudomyxoma peritonei is unusual in that radiation is rarely used: the disease coats the surfaces inside the abdomen rather than forming a single mass, and the bowel and other organs cannot safely tolerate the wide radiation field that would be needed. Instead, the 'local therapy' is delivered surgically and through heated chemotherapy washed directly through the abdomen. Radiation is reserved for occasional symptom relief — for example, a single painful or obstructing spot — where a focused, painless course of treatment can help.
The main ways radiation is delivered for pseudomyxoma peritonei:
Surgery + intraperitoneal chemotherapy (primary)
The core treatment is local, not radiation: clearing all visible disease and bathing the abdomen in heated chemotherapy to reach microscopic cells across the peritoneal surface.
Palliative external-beam radiation (rare)
In uncommon situations, focused radiation can ease a specific painful or obstructing deposit; radiation is not a routine part of treatment for this abdominal-surface disease.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Surgery plus heated chemotherapy as the standard: Large international series established cytoreductive surgery combined with HIPEC as the standard of care for appendix-origin pseudomyxoma peritonei, with long survival for patients who achieve complete removal of visible disease, especially low-grade tumors.[1]
Annals of Surgical Oncology — international PMP registry analyses
Grade predicts outcome: Pathology studies refined the classification into low-grade, high-grade, and signet-ring categories, showing that grade strongly predicts survival and helps decide who needs added systemic chemotherapy.[2]
Modern Pathology / PSOGI consensus classification
Centralizing care at expert centers: Outcome data support referring patients to high-volume peritoneal-surface-malignancy centers, where complete cytoreduction is achieved more often and complication rates are lower.[3]
Peritoneal surface malignancy outcome reviews
Common questions
Is pseudomyxoma peritonei a cancer? It is a borderline or low-grade cancerous condition in most cases. Even the slow-growing form behaves like cancer in that it spreads across the abdomen and can be life-threatening if left untreated, but it usually grows slowly and rarely spreads to distant organs through the bloodstream.
Why is radiation not the main treatment? The disease coats the lining and surfaces throughout the abdomen rather than forming one mass, and the bowel cannot safely receive radiation over such a wide area. The most effective local treatment is surgery to remove all visible disease combined with heated chemotherapy delivered directly into the abdomen.
Can it come back, and can it be treated again? Yes. Because it tends to stay within the abdomen, mucus can slowly rebuild, and many patients can have repeat surgery if needed. Long-term follow-up at an experienced center helps catch and manage any return early.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Annals of Surgical Oncology — international PMP registry analyses (no indexed identifier — see your care team) ↩
- Modern Pathology / PSOGI consensus classification (no indexed identifier — see your care team) ↩
- Peritoneal surface malignancy outcome reviews (no indexed identifier — see your care team) ↩